Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 10-Apr-24 8:50 PM View:  | Synta Pharmaceuticals Corp. (MDGL) | 08-Apr-24 | Option Exercise | 26,270 | $9.45 | $248,252.00 | 3% 841.27K to 867.54K | |
| 10-Apr-24 8:50 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 08-Apr-24 | Planned Option Sale | 26,270 | $246.19 | $6,467,490.00 | (3%) 867.54K to 841.27K | |
| 05-Apr-24 8:50 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 05-Apr-24 | Option Exercise | 27,613 | $9.45 | $260,943.00 | 3% 841.27K to 868.89K | |
| 05-Apr-24 8:50 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 05-Apr-24 | Planned Option Sale | 27,613 | $243.40 | $6,721,080.00 | (3%) 868.89K to 841.27K | |
| 05-Apr-24 8:50 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 04-Apr-24 | Option Exercise | 18,710 | $9.45 | $176,810.00 | 2% 841.27K to 859.99K | |
| 05-Apr-24 8:50 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 04-Apr-24 | Planned Option Sale | 18,710 | $242.96 | $4,545,720.00 | (2%) 859.99K to 841.27K | |
| 05-Apr-24 8:50 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 03-Apr-24 | Option Exercise | 27,407 | $9.45 | $258,996.00 | 3% 841.27K to 868.68K | |
| 05-Apr-24 8:50 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 03-Apr-24 | Planned Option Sale | 27,407 | $245.12 | $6,718,000.00 | (3%) 868.68K to 841.27K | |
| 18-Jan-23 8:00 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 16-Jan-23 | Grant | 26,668 | -- | -- | 3% 816.86K to 843.53K | |
| 18-Jan-24 1:47 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 16-Jan-23 | Payment of Exercise | 2,254 | $243.92 | $549,796.00 | (< 1%) 843.53K to 841.27K | |
| 23-Jul-21 4:51 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 21-Jul-21 | Disposition | 12,840 | -- | -- | (100%) 12.84K to 0 | |
| 24-May-21 4:34 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 20-May-21 | Grant | 2,495 | -- | -- | 24% 10.35K to 12.84K | |
| 30-Sep-20 7:53 PM View: | Prelude Therapeutics Inc (PRLD) | 29-Sep-20 | Conversion | 448,370 | -- | -- | 867% 51.73K to 500.1K | |
| 28-May-20 4:27 PM View: | Incyte Corp (INCY) | 26-May-20 | Grant | 1,282 | -- | -- | < 1% 270.53K to 271.81K | |
| 18-May-20 5:12 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 14-May-20 | Grant | 3,468 | -- | -- | 50% 6.88K to 10.35K | |
| 06-Aug-19 6:45 PM View: | Incyte Corp (INCY) | 06-Aug-19 | Option Exercise | 77,934 | $18.32 | $1,427,750.00 | 29% 270.53K to 348.46K | |
| 06-Aug-19 6:45 PM View: | Incyte Corp (INCY) | 06-Aug-19 | Market Option Sale | 77,934 | $82.20 | $6,406,170.00 | (22%) 348.46K to 270.53K | (6%) |
| 06-Aug-19 6:45 PM View: | Incyte Corp (INCY) | 02-Aug-19 | Option Exercise | 22,066 | $18.32 | $404,249.00 | 8% 270.53K to 292.6K | |
| 06-Aug-19 6:45 PM View: | Incyte Corp (INCY) | 02-Aug-19 | Market Option Sale | 22,066 | $84.41 | $1,862,590.00 | (8%) 292.6K to 270.53K | (4%) |
| 17-May-19 4:31 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 15-May-19 | Grant | 2,726 | -- | -- | 66% 4.15K to 6.88K | |
| 29-Apr-19 5:20 PM View: | Incyte Corp (INCY) | 26-Apr-19 | Grant | 1,520 | -- | -- | < 1% 269.01K to 270.53K | |
| 23-Nov-18 8:53 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 20-Nov-18 | Market Purchase | 4,000 | $117.88 | $471,520.00 | 3% 157.13K to 161.13K | 15% |
| 19-Nov-18 6:26 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 19-Nov-18 | Market Purchase | 4,000 | $124.00 | $496,000.00 | 3% 153.13K to 157.13K | 9% |
| 12-Jun-18 8:56 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 11-Jun-18 | Market Sale Duplicate | 73,526 | $287.46 | $21,135,800.00 | (10%) 729.07K to 655.54K | 53% |
| 11-May-18 4:10 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 09-May-18 | Grant | 2,174 | -- | -- | 110% 1.98K to 4.15K | |
| 30-Nov-17 4:12 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 29-Nov-17 | Grant | 1,977 | -- | -- | 100% 0 to 1.98K | |
| 20-Nov-17 4:25 PM View: | Incyte Corp (INCY) | 16-Nov-17 | Market Sale | 28,507 | $105.24 | $3,000,080.00 | (10%) 297.52K to 269.01K | 17% |
| 05-Apr-17 4:33 PM View: | Cerulean Pharma Inc. (DARE) | 03-Apr-17 | Grant | 10,273 | $0.73 | $7,499.29 | 120% 8.55K to 18.82K | (81%) |
| 20-Mar-17 4:10 PM View: | Incyte Corp (INCY) | 17-Mar-17 | Option Exercise | 41,693 | $18.32 | $763,816.00 | 14% 297.52K to 339.21K | |
| 20-Mar-17 4:10 PM View: | Incyte Corp (INCY) | 17-Mar-17 | Market Option Sale | 41,693 | $148.18 | $6,178,070.00 | (12%) 339.21K to 297.52K | 41% |
| 20-Mar-17 4:10 PM View: | Incyte Corp (INCY) | 16-Mar-17 | Option Exercise | 8,307 | $18.32 | $152,184.00 | 3% 297.52K to 305.82K | |
| 20-Mar-17 4:10 PM View: | Incyte Corp (INCY) | 16-Mar-17 | Market Option Sale | 8,307 | $151.45 | $1,258,100.00 | (3%) 305.82K to 297.52K | 42% |
| 27-Feb-17 4:54 PM View: | Incyte Corp (INCY) | 23-Feb-17 | Option Exercise | 50,000 | $18.32 | $916,000.00 | 17% 297.52K to 347.52K | |
| 27-Feb-17 4:54 PM View: | Incyte Corp (INCY) | 23-Feb-17 | Market Option Sale | 50,000 | $120.32 | $6,016,000.00 | (14%) 347.52K to 297.52K | 27% |
| 05-Jan-17 4:20 PM View: | Cerulean Pharma Inc. (DARE) | 03-Jan-17 | Grant | 4,870 | $0.77 | $3,749.90 | 132% 3.68K to 8.55K | (82%) |
| 20-Oct-16 6:57 PM View: | Cerulean Pharma Inc. (DARE) | 03-Oct-16 | Grant | 3,676 | $1.02 | $3,749.52 | 100% 0 to 3.68K | (85%) |
| 26-Jul-16 5:26 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 22-Jul-16 | Grant | 143,703 | -- | -- | 100% 0 to 143.7K | |
| 26-Jul-16 5:26 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 22-Jul-16 | Grant Duplicate | 729,066 | -- | -- | 507% 143.7K to 872.77K | |
| 19-Nov-15 5:51 PM View: | Incyte Corp (INCY) | 18-Nov-15 | Option Exercise | 125,000 | $17.79 | $2,223,750.00 | 42% 297.52K to 422.52K | |
| 19-Nov-15 5:51 PM View: | Incyte Corp (INCY) | 18-Nov-15 | Market Option Sale | 125,000 | $115.33 | $14,415,800.00 | (30%) 422.52K to 297.52K | 24% |
| 19-Nov-15 5:51 PM View: | Incyte Corp (INCY) | 17-Nov-15 | Option Exercise | 100,000 | $17.79 | $1,779,000.00 | 34% 297.52K to 397.52K | |
| 19-Nov-15 5:51 PM View: | Incyte Corp (INCY) | 17-Nov-15 | Market Option Sale | 100,000 | $111.96 | $11,196,300.00 | (25%) 397.52K to 297.52K | 22% |
| 06-Jul-15 4:36 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 01-Jul-15 | Grant | 6,817 | -- | -- | 100% 0 to 6.82K | |
| 28-May-15 4:32 PM View: | Incyte Corp (INCY) | 27-May-15 | Option Exercise | 69,132 | $14.72 | $1,017,620.00 | 23% 297.52K to 366.65K | |
| 28-May-15 4:32 PM View: | Incyte Corp (INCY) | 27-May-15 | Market Option Sale | 69,132 | $107.55 | $7,435,030.00 | (19%) 366.65K to 297.52K | 19% |
| 28-May-15 4:32 PM View: | Incyte Corp (INCY) | 26-May-15 | Option Exercise | 127,619 | $14.72 | $1,878,550.00 | 43% 297.52K to 425.14K | |
| 28-May-15 4:32 PM View: | Incyte Corp (INCY) | 26-May-15 | Market Option Sale | 127,619 | $107.05 | $13,661,700.00 | (30%) 425.14K to 297.52K | 18% |
| 26-May-15 4:57 PM View: | Incyte Corp (INCY) | 22-May-15 | Option Exercise | 79,592 | $14.72 | $1,171,590.00 | 27% 297.52K to 377.11K | |
| 26-May-15 4:57 PM View: | Incyte Corp (INCY) | 22-May-15 | Market Option Sale | 79,592 | $108.04 | $8,599,180.00 | (21%) 377.11K to 297.52K | 19% |
| 26-May-15 4:57 PM View: | Incyte Corp (INCY) | 21-May-15 | Option Exercise | 22,651 | $14.72 | $333,423.00 | 8% 297.52K to 320.17K |